Hepatitis E virus (HEV) genotype 3 infection of human liver chimeric mice as a model for chronic HEV infection

Journal of Virology

Volumn 90, Issue 9, 2016, Pages 4394-4401

  Van De Garde, Martijn D B ^a   Pas, Suzan D ^a   Van Der Net, Guido ^a   De Man, Robert A ^a   Osterhaus, Albert D M E ^a   Haagmans, Bart L ^a   Boonstra, Andre ^a   Vanwolleghem, Thomas ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 3; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TITRATION; VIRUS TRANSMISSION; ANIMAL; CELL LINE; CHRONIC DISEASE; DISEASE MODEL; GENETICS; GENOTYPE; HOST PATHOGEN INTERACTION; LIVER CELL; METABOLISM; TRANSPLANTATION; VIROLOGY;

ANIMALS; CELL LINE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; VIRAL LOAD; VIRUS REPLICATION;

EID: 84964961858     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00114-16     Document Type: Article

References (32)

1. Smith DB, Simmonds P, International Committee on Taxonomy of Viruses Hepeviridae Study Group, Jameel S, Emerson SU, Harrison TJ, Meng XJ, Okamoto H, Van der Poel WH, Purdy MA. 2014. Consensus proposals for classification of the family Hepeviridae. J Gen Virol 95: 2223-2232. http://dx.doi.org/10.1099/vir.0.068429-0.
2. Aggarwal R, Jameel S. 2011. Hepatitis E. Hepatology 54:2218-2226. http://dx.doi.org/10.1002/hep.24674.
3. Krain LJ, Nelson KE, Labrique AB. 2014. Host immune status and response to hepatitis E virus infection. Clin Microbiol Rev 27:139-165. http://dx.doi.org/10.1128/CMR.00062-13.
4. Koning L, Pas SD, de Man RA, Balk AH, de Knegt RJ, ten Kate FJ, Osterhaus AD, van der Eijk AA. 2013. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant 32:78-85. http://dx.doi.org/10.1016/j.healun.2012.10.008.
5. Koot H, Hogema BM, Koot M, Molier M, Zaaijer HL. 2015. Frequent hepatitis E in the Netherlands without traveling or immunosuppression. J Clin Virol 62:38-40. http://dx.doi.org/10.1016/j.jcv.2014.11.020.
6. Mansuy JM, Saune K, Rech H, Abravanel F, Mengelle C, L Homme S, Destruel F, Kamar N, Izopet J. 2015. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011. Euro Surveill 20(119):pii:21127. http://dx.doi.org/10.2807/1560-7917.ES2015.20.19.21127.
7. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, Kennedy IT, Kitchen A, Patel P, Poh J, Russell K, Tettmar KI, Tossell J, Ushiro-Lumb I, Tedder RS. 2014. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 384: 1766-1773. http://dx.doi.org/10.1016/S0140-6736(14)61034-5.
8. Hogema BM, Molier M, Slot E, Zaaijer HL. 2014. Past and present of hepatitis E in the Netherlands. Transfusion 54:3092-3096. http://dx.doi.org/10.1111/trf.12733.
9. Wenzel JJ, Sichler M, Schemmerer M, Behrens G, Leitzmann MF, Jilg W. 2014. Decline in hepatitis E virus antibody prevalence in southeastern Germany, 1996-2011. Hepatology 60:1180-1186. http://dx.doi.org/10.1002/hep.27244.
10. Zaaijer HL. 2014. No artifact, hepatitis E is emerging. Hepatology http://dx.doi.org/10.1002/hep.27611.
11. Rutjes SA, Lodder WJ, Lodder-Verschoor F, van den Berg HHJL, Vennema H, Duizer E, Koopmans M, Husman AMD. 2009. Sources of hepatitis E virus genotype 3 in the Netherlands. Emerg Infect Dis 15:381-387. http://dx.doi.org/10.3201/eid1503.071472.
12. Vanwolleghem T, Libbrecht L, Hansen BE, Desombere I, Roskams T, Meuleman P, Leroux-Roels G. 2010. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. J Hepatol 53:468-476. http://dx.doi.org/10.1016/j.jhep.2010.03.024.
13. Vanwolleghem T, Bukh J, Meuleman P, Desombere I, Meunier JC, Alter H, Purcell RH, Leroux-Roels G. 2008. Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain. Hepatology 47:1846-1855. http://dx.doi.org/10.1002/hep.22244.
14. Vanwolleghem T, Meuleman P, Libbrecht L, Roskams T, De Vos R, Leroux-Roels G. 2007. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse. Gastroenterology 133:1144-1155. http://dx.doi.org/10.1053/j.gastro.2007.07.007.
15. Giersch K, Allweiss L, Volz T, Helbig M, Bierwolf J, Lohse AW, Pollok JM, Petersen J, Dandri M, Lutgehetmann M. 2015. Hepatitis delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. J Hepatol 63: 346-353. http://dx.doi.org/10.1016/j.jhep.2015.03.011.
16. Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma IM. 2010. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 120:924-930. http://dx.doi.org/10.1172/JCI40094.
17. Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, Sprinzl MF, Koppensteiner H, Makowska Z, Volz T, Remouchamps C, Chou WM, Thasler WE, Huser N, Durantel D, Liang TJ, Munk C, Heim MH, Browning JL, Dejardin E, Dandri M, Schindler M, Heikenwalder M, Protzer U. 2014. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343:1221-1228. http://dx.doi.org/10.1126/science.1243462.
18. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G, Rice CM. 2006. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A 103:3805-3809. http://dx.doi.org/10.1073/pnas.0511218103.
19. Suemizu H, Hasegawa M, Kawai K, Taniguchi K, Monnai M, Wakui M, Suematsu M, Ito M, Peltz G, Nakamura M. 2008. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rg(null) mice. Biochem Biophys Res Commun 377:248-252. http://dx.doi.org/10.1016/j.bbrc.2008.09.124.
20. Tanaka T, Takahashi M, Kusano E, Okamoto H. 2007. Development and evaluation of an efficient cell-culture system for hepatitis E virus. J Gen Virol 88:903-911. http://dx.doi.org/10.1099/vir.0.82535-0.
21. Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, Osterhaus AD, Cornelissen JJ, van der Eijk AA. 2013. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 122:1079-1086. http://dx.doi.org/10.1182/blood-2013-03-492363.
22. Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT, Weimar W, Koopmans MP, Osterhaus AD, van der Eijk AA. 2012. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 18:869-872. http://dx.doi.org/10.3201/eid1805.111712.
23. Nagashima S, Takahashi M, Jirintai S, Tanggis Kobayashi T, Nishizawa T, Okamoto H. 2014. The membrane on the surface of hepatitis E virus particles is derived from the intracellular membrane and contains trans-Golgi network protein 2. Arch Virol 159:979-991. http://dx.doi.org/10.1007/s00705-013-1912-3.
24. Takahashi M, Yamada K, Hoshino Y, Takahashi H, Ichiyama K, Tanaka T, Okamoto H. 2008. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch Virol 153:1703-1713. http://dx.doi.org/10.1007/s00705-008-0179-6.
25. Okamoto H. 2013. Culture systems for hepatitis E virus. J Gastroenterol 48:147-158. http://dx.doi.org/10.1007/s00535-012-0682-0.
26. Johne R, Reetz J, Ulrich RG, Machnowska P, Sachsenroder J, Nickel P, Hofmann J. 2014. An ORF1-rearranged hepatitis E virus derived from a chronically infected patient efficiently replicates in cell culture. J Viral Hepat 21:447-456. http://dx.doi.org/10.1111/jvh.12157.
27. Nguyen HT, Torian U, Faulk K, Mather K, Engle RE, Thompson E, Bonkovsky HL, Emerson SU. 2012. A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture. J Gen Virol 93:526-530. http://dx.doi.org/10.1099/vir.0.037259-0.
28. Shukla P, Nguyen HT, Faulk K, Mather K, Torian U, Engle RE, Emerson SU. 2012. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol 86:5697-5707. http://dx.doi.org/10.1128/JVI.00146-12.
29. Shukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR, Bendall RP, Keane FE, Purcell RH, Emerson SU. 2011. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A 108:2438-2443. http://dx.doi.org/10.1073/pnas.1018878108.
30. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, Sato S, Kato T, Nishimori H, Tsuji K, Maguchi H, Yoshida J, Maekubo H, Mishiro S, Ikeda H. 2008. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 48:1368-1375. http://dx.doi.org/10.1111/j.1537-2995.2008.01722.x.
31. Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, Kato T, Takahashi K, Mishiro S, Imai M, Takeda N, Ikeda H. 2004. Transfusiontransmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 44:934-940. http://dx.doi.org/10.1111/j.1537-2995.2004.03300.x.
32. Pawlotsky JM. 2014. Hepatitis E screening for blood donations: an urgent need? Lancet 384:1729-1730. http://dx.doi.org/10.1016/S0140-6736(14)61187-9.